We are testing a new oral medication for patients with advanced or metastatic solid tumors that have a specific genetic mutation. The goal is to see if it can help improve treatment outcomes.
Health conditions and diseases that the clinical trial is designed to study and treat.
Esophageal, gastric, or gastroesophageal junction adenocarcinoma is a type of cancer that forms in the glands of the esophagus or stomach, often leading to symptoms like difficulty swallowing, weight loss, and stomach pain.
Esophageal, gastric, or gastroesophageal junction squamous cell carcinoma is a type of cancer that arises from the squamous cells lining the esophagus or stomach, commonly presenting with symptoms such as difficulty swallowing and chest pain.
Non-small cell lung cancer (NSCLC) is a common type of lung cancer that can develop in different parts of the lung, often causing symptoms like a persistent cough, chest pain, and shortness of breath.
Advanced or metastatic solid tumors with a SMARCA4 mutation are cancers that have spread beyond their original site and have a specific genetic mutation, often leading to varied symptoms depending on the tumor's location.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.